Abstract
Background: The EL4 cell line was previously derived from a lymphoma induced in a C57/BL6 mouse by 9,10-dimethyl-1,2-benzanthracene. In a previous study, EL4 lymphoma cells expressing red fluorescent protein (EL4-RFP) were established and injected into the tail vein of C57/BL6 green fluorescent protein (GFP) transgenic mice. Metastasis was observed at multiple sites which were also enriched with host GFP-expressing stromal cells. In the present study, our aim was to establish an orthotopic model of EL4-RFP. Materials and Methods: In the present study, EL4-RFP lymphoma cells were injected in the spleen of C57/BL6 GFP transgenic mice as an orthotopic model of lymphoma. Resultant primary tumor and metastases were imaged with the Olympus FV1000 scanning laser confocal microscope. Results: EL4-RFP metastasis was observed 21 days later. EL4-RFP tumors in the spleen (primary injection site), liver, supra-mediastinum lymph nodes, abdominal lymph nodes, bone marrow, and lung were visualized by color-coded imaging. EL4-RFP metastases in the liver, lymph nodes, and bone marrow in C57/BL6 GFP mice were rich in GFP stromal cells such as macrophages, fibroblasts, dendritic cells, and normal lymphocytes derived from the host animal. Small tumors were observed in the spleen, which were rich in host stromal cells. In the lung, no mass formation of lymphoma cells occurred, but lymphoma cells circulated in lung peripheral blood vessels. Phagocytosis of EL4-RFP lymphoma cells by macrophages, as well as dendritic cells and fibroblasts, were observed in culture. Conclusion: Color-coded imaging of the lymphoma microenvironment suggests an important role of stromal cells in lymphoma progression and metastasis.
With the use of multiple colored proteins, we have developed imaging of the tumor microenvironment (TME) by color-coding cancer and stromal cells (1-21). The TME is necessary for tumor growth and progression of disease (5). Color-coded imaging technology of the TME used green fluorescent protein (GFP) (2), red fluorescent protein (RFP) (7), or cyan fluorescent protein (CFP) (8) transgenic nude mice as hosts into which we transplanted cancer cells expressing a fluorescent protein not expressed by the host (1-21).
Tumors contain fibroblasts, lymphocytes, dendritic cells, macrophages and other myeloid cells in their microenvironment (22). Cancer-associated fibroblasts (CAFs) stimulate cancer cell growth, inflammation, angiogenesis, and invasion (22-26). As a tumor grows, it recruits CAFs and other host cells (27, 28). We reported the importance of CAFs in metastasis to the liver (9, 12). Non-colored HCT-116 human colon cancer cells were injected into the spleen of GFP-expressing nude mice which led to the formation of experimental liver metastases. GFP-expressing host cells were recruited by the metastatic tumors as visualized by fluorescence imaging. A desmin-positive area increased around and within the liver metastasis over time, suggesting CAFs were recruited by the liver metastasis, and appeared to have a role in its progression (9).
A syngeneic color-coded imageable lymphoma model was previously developed to visualize recruitment of host stromal cells by malignant lymphoma during experimental metastasis. The EL4 cell line was derived from a lymphoma induced in a C57/BL6 mouse by 9,10-dimethyl-1,2-benzanthracene. EL4 lymphoma cells expressing RFP (EL4-RFP) were established and injected into the tail vein of C57/BL6-GFP transgenic mice. EL4-RFP experimental metastasis was observed in the lymph nodes of the upper mediastinum and in the liver 28 days after cell injection. Large EL4-RFP liver metastases in C57/BL6-GFP mice contained GFP-expressing stromal cells derived from the host. In addition, EL4-RFP lymphoma metastasis was formed in peri-gastric lymph nodes, which were also enriched in host GFP-expressing cells. EL4-RFP lymphoma cells were also observed in the peripheral blood and bone marrow, where they were associated with GFP-expressing host cells (29).
The present study utilized color-coded fluorescent protein-based imaging to visualize the recruitment over time of host cells by lymph-node and liver metastases of the EL4-RFP lymphoma implanted in the spleen in syngeneic mice to establish an orthotopic model (29).
Materials and Methods
GFP transgenic mice. Transgenic C57/BL6-GFP mice (30) were obtained from the Research Institute for Microbial Diseases (Osaka University, Osaka, Japan). The C57/BL6-GFP mice expressed Aequorea victoria GFP under the control of the chicken β-actin promoter and cytomegalovirus enhancer (29).
Cell line and culture conditions. EL4, a mouse lymphoma cell line was established from a lymphoma induced in a C57/BL6 mouse by 9,10-dimethyl-1,2-benzanthracene (31). The cells were maintained in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1% penicillin and streptomycin (Gibco-BRL, Grand Island, NY). The cells were cultured at 37°C in a 5% CO2 incubator (29).
RFP fluorescent protein transduction of lymphoma cells. Mouse EL4 lymphoma cells were labeled with RFP as previously reported using a retrovirus-based vector expressing RFP (4, 29, 32, 33).
Color-coded lymphoma-host cell model. Six-week-old GFP immunocompetent C57/BL6-GFP transgenic mice were used as the host for EL4-RFP lymphoma cells. EL4-RFP lymphoma cells growing in vitro were first harvested and washed three times with cold serum-free medium and then resuspended with serum-free RPMI-1640 medium. EL4-RFP lymphoma cells were injected in the spleen of C57/BL6-GFP transgenic mice (29).
Tumor imaging. SZX7 microscope, and FV1000 confocal microscope, all from Olympus Corp. (Tokyo, Japan), were used for imaging in this study (29).
Study approval. All experiments were conducted in accordance with the institutional guidelines of Gifu University and were approved by the Animal Research Committee and the Committee on Living Modified Organisms of Gifu University (approval number 26-37) (29).
Results and Discussion
EL4-RFP mouse malignant lymphoma cancer cells were injected in the spleen of GFP mice. EL4-RFP metastasis was observed in the liver (Figure 1A), in the lymph nodes of the upper mediastinum and abdomen (Figure 2C,E), and bone marrow (Figure 3F) after 21 days.
High-magnification confocal fluorescence microscopy showed extensive GFP fluorescence within and around RFP-expressing tumors indicating extensive recruitment of stromal cells. A large EL4-RFP liver metastases in a C57/BL6 GFP mouse had GFP stromal cells derived from the host animal around the edge of the metastasis (Figure 1B). The stromal cells included macrophages, dendric cells, lymphocytes, and fibroblasts.
In contrast to the liver and the lymph nodes, a small lymphoma was observed in the spleen at the primary injection site. However, the stroma cells in the spleen tumors were abundant (Figure 1C,D).
EL4-RFP lymphoma cells metastasis, formed in abdominal lymph nodes and mediastinal lymph nodes, also contained stromal cells which accumulated at the edge of the tumor. (Figure 2A-D).
EL4-RFP lymphoma cells also circulated in the peripheral blood in the lung and brain, although no metastasis occurred in these organs (Figure 1E,F and 2A,B).
Lymphoma cells from multiple metastases were cultured in vitro (Figure 3). Phagocytosis of lymphoma cells by macrophages, as well as fibroblasts and dendritic cells were observed in the cultures of the spleen and each metastatic lesion (at one and four days of culture). Interestingly, no metastasis formation was observed in the lungs and the brain where macrophages, fibroblasts, dendritic cells in addition to lymphoma cells did not infiltrate into the organ tissue.
Thus, we have demonstrated a color-coded imaging model in which the development of the TME during lymphatic and hematogenous metastasis can be visualized in a syngeneic orthotopic model of metastatic lymphoma. In GFP-expressing transgenic mice, only non-parenchymal cells of the liver have GFP fluorescence (29), which makes it a very high-contrast model for imaging stromal recruitment by liver metastases. The orthotopic model of malignant lymphoma can be used to study early tumor development, metastasis and the role of stroma, for the discovery and evaluation of novel therapeutics for targeting both the lymphoma and its host stromal cells.
Footnotes
This article is freely accessible online.
Conflict of Interest
None of the Authors have any conflict of interest in regard to this study.
- Received January 26, 2016.
- Revision received February 25, 2016.
- Accepted February 26, 2016.
- Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved